COST-EFFECTIVENESS ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE

被引：0
|
作者：
Belousov, D. [1 ]
Afanasieva, E. [2 ]
机构：
[1] Ctr Pharmacoecon Res LLC, Moscow, Russia
[2] LLC Ctr Pharmacoecon Res, Moscow, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2466
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND51
引用
收藏
页码：A757 / A757
页数：1
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
    Belousov, D.
    Afanasieva, E.
    VALUE IN HEALTH, 2015, 18 (07) : A758 - A759
  • [2] Cost-effectiveness analysis of pramipexole in early Parkinson's disease
    Noyes, K
    Dick, AW
    Holloway, RG
    VALUE IN HEALTH, 2003, 6 (03) : 274 - 274
  • [3] BUDGET IMPACT ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
    Belousov, D.
    Afanasieva, E.
    VALUE IN HEALTH, 2015, 18 (07) : A752 - A753
  • [4] Cost-effectiveness of pramipexole compared with piribedil in early Parkinson's disease patients
    Chikina, ES
    Gusev, EL
    Belousov, YB
    Guecht, AB
    VALUE IN HEALTH, 2005, 8 (03) : 321 - 321
  • [5] Cost-effectiveness of pramipexole in Parkinson's disease in the United States
    Hoerger, TJ
    Bala, MV
    Rowland, C
    Greer, M
    Holloway, R
    NEUROLOGY, 1998, 50 (04) : A298 - A299
  • [6] Pramipexole extended release in Parkinson's disease
    Hametner, Eva-Maria
    Seppi, Klaus
    Poewe, Werner
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (09) : 1229 - 1234
  • [7] Pramipexole Extended Release In Parkinson's Disease
    Chwieduk, Claudine M.
    Curran, Monique P.
    CNS DRUGS, 2010, 24 (04) : 327 - 336
  • [8] Pramipexole extended-release is effective in early Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R. A.
    Mizuno, Y.
    Rascol, O.
    Schapira, A.
    Haaksma, M.
    Juhel, N.
    MOVEMENT DISORDERS, 2009, 24 : S273 - S273
  • [9] Cost effectiveness of pramipexole in Parkinson's disease in the US
    Hoerger, TJ
    Bala, MV
    Rowland, C
    Greer, M
    Chrischilles, EA
    Holloway, RG
    PHARMACOECONOMICS, 1998, 14 (05) : 541 - 557
  • [10] Pramipexole and levodopa in early Parkinson's disease - Dynamic changes in cost effectiveness
    Noyes, K
    Dick, AW
    Holloway, RG
    PHARMACOECONOMICS, 2005, 23 (12) : 1257 - 1270
12345